The UK mid-market firm has strengthened its team, as it continues to invest its latest fund raised this year.
1 min read · 04 January 2013
The UK mid-market firm has made a three times return in six and a half years, selling Summit Medical to The Riverside Company, after a refinancing in 2005.
2 min read · 04 January 2013
As the international banking industry continues to reshape itself, UBS’ Lorne Somerville is the latest senior figure to head for the private equity industry.
1 min read · 04 January 2013
Mark Wolfson, the co-founder of private equity firm Oak Hill, believes the prospects for the asset class generally are strong, and worries about 2006 and 2007 funds have been overdone.
2 min read · 04 January 2013
Marcel Herter is the latest of a number of high-ranking investment bankers to leave a job in leveraged finance recently.
1 min read · 04 January 2013
The firm’s fundraising for its second venture debt fund has closed with commitments from all of its debut fund’s investors.
2 min read · 04 January 2013
The French investment firm could have profited even further were it not for hedging costs relating to its stake-building in Saint Gobain, which has dropped in value by nearly 30 percent.
2 min read · 04 January 2013
Deal volume in Europe’s first quarter was down even in sectors which don’t depend on leverage, as the number of private equity deals fell to its lowest quarterly total since 2004, according to Candover.
2 min read · 04 January 2013
The global mid-market buyout firm attracted interest nearly double its planned €5bn target, but it scaled back the fund giving existing limited partners priority.
2 min read · 04 January 2013
After a tough year in 2007 providers of the hybrid form of debt are likely to capitalise fully on the disappearance of competition to finance leveraged buyouts.
2 min read · 04 January 2013
